Aspirin Is as Effective and Safe as Oral Anticoagulants for Venous Thromboembolism Prophylaxis After Joint Arthroplasty
Aspirin ist zur VTE-Prophylaxe nach Gelenkarthroplastik ebenso wirksam und sicher wie orale Antikoagulanzien
Journal of Bone and Joint Surgery · 02.04.2025 · 107 (7) · 760-770
DOI: 10.2106/jbjs.24.00946 ↗Auf einen Blick
Eine systematische Übersicht mit Metaanalyse von 11 RCTs fand für Aspirin und orale Antikoagulanzien nach Gelenkarthroplastik ähnliche Ergebnisse zur VTE-Prophylaxe. Auch bei Blutung, Wundkomplikationen und Mortalität zeigten sich keine Unterschiede.
Fragestellung
Ist Aspirin im Vergleich zu oralen Antikoagulanzien zur VTE-Prophylaxe nach Gelenkarthroplastik wirksam und sicher?
Methode
Systematische Übersicht und Metaanalyse von RCTs; Suche in PubMed, Embase, Web of Science und Cochrane Library bis 14. Mai 2024; random-effects Modell.
Ergebnisse
11 RCTs mit 4.717 Teilnehmenden. VTE: RR 1,11 (95 %-KI 0,93–1,32) für Aspirin vs. OACs. DVT: RR 1,12 (95 %-KI 0,90–1,40); PE: RR 1,18 (95 %-KI 0,51–2,71).
Schlussfolgerung der Autor:innen
Auf Basis hochwertiger Evidenz aus RCTs ist Aspirin nach Gelenkarthroplastik bei der Prävention von VTE, DVT und PE ebenso wirksam und sicher wie OACs, ohne mehr Komplikationen.
Kernaussagen
- VTE-Risiko unter Aspirin und OACs ähnlich
- Keine Unterschiede bei DVT, PE, Blutung oder Mortalität
- Evidenz für VTE- und DVT-Endpunkte insgesamt hoch
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Bone and Joint Surgery, online erschienen am 21.01.2025. Verfasst von Zhenghua Hong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Taizhou Hospital of Zhejiang Province affiliated with Wenzhou Medical University, Taizhou, Zhejiang, People's Republic of …. Hauptthemen laut MEDLINE: Aspirin, Venous Thromboembolism, Anticoagulants, Postoperative Complications. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Background
Joint arthroplasty effectively treats osteoarthritis, providing pain relief and improving function, but postoperative venous thromboembolism (VTE) remains a common complication. This study therefore assessed the effectiveness and safety of aspirin compared with oral anticoagulants (OACs) for VTE prophylaxis after joint arthroplasty.
Methods
A systematic review and meta-analysis was performed by searching PubMed, Embase, the Web of Science, and the Cochrane Library for randomized controlled trials (RCTs) up to May 14, 2024, that compared the effect of aspirin versus OACs on VTE prophylaxis in adults undergoing joint arthroplasty. Data extraction followed the PRISMA guidelines. Two independent researchers conducted the literature searches and data extraction. A random-effects model was used to estimate effects. The primary outcome was the incidence of VTE, including deep vein thrombosis (DVT) and pulmonary embolism (PE); secondary outcomes included bleeding, wound complications, and mortality.
Results
The meta-analysis included 11 RCTs with a total of 4,717 participants (55.1% female) from several continents. The relative risk (RR) of VTE following joint arthroplasty was 1.11 (95% confidence interval [CI], 0.93 to 1.32) for aspirin compared with OACs. Similar results were observed for DVT (RR, 1.12; 95% CI, 0.90 to 1.40) and PE (RR, 1.18; 95% CI, 0.51 to 2.71). There were no significant differences in the risks of bleeding, wound complications, or mortality between patients receiving aspirin and those receiving OACs. Subgroup analyses considering factors such as study region, type of joint surgery, type of VTE detection, year of publication, use of mechanical VTE prophylaxis, aspirin dose, type of OAC comparator, study quality, and funding also found no significant differences in VTE incidence between aspirin and OACs. The overall quality of evidence for VTE and DVT outcomes was high.
Conclusions
Based on high-quality evidence from RCTs, aspirin is as effective and safe as OACs in preventing VTE, including DVT and PE, after joint arthroplasty, without increasing complications. Level of Evidence: Therapeutic Level I . See Instructions for Authors for a complete description of levels of evidence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Taizhou Hospital of Zhejiang Province affiliated with Wenzhou Medical University, Taizhou, Zhejiang, People's Republic of China.
- Department of Orthopedics, First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, People's Republic of China.
ORCID-Profile: Yongwei Su, Liwei Zhang, Hua Luo
Zitieren
APA
Hong, Z., Su, Y., Zhang, L., & Luo, H. (2025). Aspirin Is as Effective and Safe as Oral Anticoagulants for Venous Thromboembolism Prophylaxis After Joint Arthroplasty. Journal of Bone and Joint Surgery, 107(7), 760-770. https://doi.org/10.2106/jbjs.24.00946
Vancouver
Hong Z, Su Y, Zhang L, Luo H. Aspirin Is as Effective and Safe as Oral Anticoagulants for Venous Thromboembolism Prophylaxis After Joint Arthroplasty. Journal of Bone and Joint Surgery. 2025;107(7):760-770. doi:10.2106/jbjs.24.00946
BibTeX
@article{Hong2025,
author = {Hong, Zhenghua and Su, Yongwei and Zhang, Liwei and Luo, Hua},
title = {Aspirin Is as Effective and Safe as Oral Anticoagulants for Venous Thromboembolism Prophylaxis After Joint Arthroplasty},
journal = {Journal of Bone and Joint Surgery},
year = {2025},
volume = {107},
number = {7},
pages = {760--770},
doi = {10.2106/jbjs.24.00946}
}
EUVIMED